Problem statement: Answer the MCQ question.
Question: Which compound exhibits a -2.626\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: COCCNC(=S)N=Nc1c(O)[nH]c2c(C)cc(C)cc12
b: O=C(CCN1C(=O)/C(=C\c2ccccc2)SC1=S)NCCCN1CCOCC1
c: CC(=O)c1ccc(COC(=O)c2ccccc2NC(=O)C(C)C)cc1
Answer: b. O=C(CCN1C(=O)/C(=C\c2ccccc2)SC1=S)NCCCN1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CCN1C(=O)/C(=C\c2ccccc2)SC1=S)NCCCN1CCOCC1
O=C(CCN1C(=O)/C(=C\c2ccccc2)SC1=S)NCCCN1CCOCC1
3-[(5E)-5-benzylidene-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-N-(3-morpholin-4-ylpropyl)propanamide